Silencing of HDAC1 in ovarian cancer cells was found to overcome resistance to cisplatin [125], and silencing of both HDAC1 and HDAC6 was found to enhance cytarabine-induced apoptosis of acute myeloid leukemia (AML) cells induced by cytarabine [126]. Here, HDAC1 is linked to ovarian carcinoma.